Display options
Cite
McGuire JF, Lewin AB, Geller DA, et al. Advances in the treatment of pediatric obsessive-compulsive d-cycloserine with exposure and response prevention. Neuropsychiatry (London). 2012;2(4)doi: 10.2217/npy.12.38.
McGuire, J. F., Lewin, A. B., Geller, D. A., Brown, A., Ramsey, K., Mutch, J., Mittelman, A., Micco, J., Jordan, C., Wilhelm, S., Murphy, T. K., Small, B. J., & Storch, E. A. (2012). Advances in the treatment of pediatric obsessive-compulsive d-cycloserine with exposure and response prevention. Neuropsychiatry, 2(4), . https://doi.org/10.2217/npy.12.38
McGuire, Joseph F, et al. "Advances in the treatment of pediatric obsessive-compulsive d-cycloserine with exposure and response prevention." Neuropsychiatry vol. 2,4 (2012). doi: https://doi.org/10.2217/npy.12.38
McGuire JF, Lewin AB, Geller DA, Brown A, Ramsey K, Mutch J, Mittelman A, Micco J, Jordan C, Wilhelm S, Murphy TK, Small BJ, Storch EA. Advances in the treatment of pediatric obsessive-compulsive d-cycloserine with exposure and response prevention. Neuropsychiatry (London). 2012 Aug;2(4). doi: 10.2217/npy.12.38. PMID: 24174993; PMCID: PMC3808983.
Copy Download .nbib Format: NLM
Share it on

Neuropsychiatry (London). 2012 Aug;2(4). doi: 10.2217/npy.12.38.

Advances in the treatment of pediatric obsessive-compulsive d-cycloserine with exposure and response prevention.

Neuropsychiatry

Joseph F McGuire, Adam B Lewin, Daniel A Geller, Ashley Brown, Kesley Ramsey, Jane Mutch, Andrew Mittelman, Jamie Micco, Cary Jordan, Sabine Wilhelm, Tanya K Murphy, Brent J Small, Eric A Storch

Affiliations

  1. Department of Psychology, University of South Florida, 4202 East Fowler Avenue, Tampa, FL 33620, USA ; Department of Pediactrics, University of South Florida, 880 6th Street South, Suite 460, Box 7523, St Petersburg, FL 33701, USA.

PMID: 24174993 PMCID: PMC3808983 DOI: 10.2217/npy.12.38

Abstract

Exposure-based cognitive-behavioral therapy and serotonin reuptake inhibitor medications are efficacious treatment options for the management of pediatric obsessive-compulsive disorder. Despite established efficacy, many youths receiving either therapy remain symptomatic after acute treatment. Regardless of the rationale for persistent symptoms, a clear need emerges for treatment options that restore functioning efficiently to symptomatic youths. One innovative approach builds upon the identified role of NMDA receptors in the fear extinction process. Instead of breaking existing connections during fear extinction, new associations develop that eventually predominate over prior associations. Recent investigations have explored augmenting exposure-based cognitive-behavioral therapy with the NMDA partial agonist d-cycloserine, with preliminary results demonstrating expedited treatment gains and moderately larger effects above exposure and response prevention therapy alone. A large randomized clinical trial is underway to evaluate the efficacy and efficiency of this therapeutic combination in pediatric obsessive-compulsive disorder. Results from this trial may translate into improved management practices.

References

  1. Biol Psychiatry. 2005 Apr 15;57(8):841-7 - PubMed
  2. Soc Psychiatry Psychiatr Epidemiol. 2009 Nov;44(11):935-42 - PubMed
  3. Expert Rev Neurother. 2011 Feb;11(2):287-98 - PubMed
  4. Med Care. 1999 Feb;37(2):126-39 - PubMed
  5. Behav Neurosci. 1996 Jun;110(3):618-20 - PubMed
  6. J Child Psychol Psychiatry. 2008 May;49(5):489-98 - PubMed
  7. J Am Acad Child Adolesc Psychiatry. 2008 Jan;47(1):94-102 - PubMed
  8. Arch Gen Psychiatry. 1982 Aug;39(8):879-83 - PubMed
  9. J Am Acad Child Adolesc Psychiatry. 1997 Apr;36(4):554-65 - PubMed
  10. JAMA. 2011 Sep 21;306(11):1224-32 - PubMed
  11. J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980-8 - PubMed
  12. Psychiatry Res. 2011 Oct 30;189(3):407-12 - PubMed
  13. Nord J Psychiatry. 2008;62 Suppl 47:37-44 - PubMed
  14. J Child Adolesc Psychopharmacol. 2009 Jun;19(3):289-96 - PubMed
  15. Neuropsychopharmacology. 2010 Sep;35(10):2134-42 - PubMed
  16. J Am Acad Child Adolesc Psychiatry. 1998 Oct;37(10 Suppl):27S-45S - PubMed
  17. J Nerv Ment Dis. 1999 Oct;187(10):636-42 - PubMed
  18. J Clin Psychopharmacol. 2011 Dec;31(6):763-8 - PubMed
  19. J Clin Psychiatry. 2002 Jan;63(1):21-7 - PubMed
  20. Am J Psychiatry. 2008 Mar;165(3):335-41; quiz 409 - PubMed
  21. Psychiatry Res. 2004 Nov 30;129(1):91-8 - PubMed
  22. Ann Clin Psychiatry. 2004 Jul-Sep;16(3):127-32 - PubMed
  23. Int Rev Psychiatry. 2008 Apr;20(2):203-8 - PubMed
  24. J Affect Disord. 2012;138 Suppl:S22-30 - PubMed
  25. Child Adolesc Psychiatr Clin N Am. 1999 Jul;8(3):445-60 - PubMed
  26. Biol Psychiatry. 2008 Mar 15;63(6):544-9 - PubMed
  27. Behav Ther. 2011 Sep;42(3):399-412 - PubMed
  28. JAMA. 2009 Oct 28;302(16):1765-73 - PubMed
  29. Cochrane Database Syst Rev. 2010 Dec 08;(12):CD008141 - PubMed
  30. J Clin Child Adolesc Psychol. 2007 Oct-Dec;36(4):645-53 - PubMed
  31. Dialogues Clin Neurosci. 2011;13(4):463-74 - PubMed
  32. J Am Acad Child Adolesc Psychiatry. 2007 Apr;46(4):469-478 - PubMed
  33. Biol Psychiatry. 2007 Oct 15;62(8):835-8 - PubMed
  34. J Am Acad Child Adolesc Psychiatry. 2012 Jan;51(1):98-113 - PubMed
  35. Psychopharmacology (Berl). 2007 Mar;191(1):87-96 - PubMed
  36. Biol Psychiatry. 2012 Jun 1;71(11):962-8 - PubMed
  37. J Child Adolesc Psychopharmacol. 2003;13 Suppl 1:S61-9 - PubMed
  38. Behav Neurosci. 2006 Oct;120(5):1159-62 - PubMed
  39. Depress Anxiety. 2010 Jun;27(6):556-72 - PubMed
  40. J Cogn Psychother. 2009;23(4):294-305 - PubMed
  41. Drug Alcohol Depend. 2009 Oct 1;104(3):220-7 - PubMed
  42. JAMA. 2004 Oct 27;292(16):1969-76 - PubMed
  43. Arch Gen Psychiatry. 2006 Mar;63(3):298-304 - PubMed
  44. J Neurosci. 2001 Nov 15;21(22):9009-17 - PubMed
  45. J Am Acad Child Adolesc Psychiatry. 1997 Jun;36(6):844-52 - PubMed
  46. J Anxiety Disord. 2010 Mar;24(2):275-83 - PubMed
  47. Am J Psychiatry. 2005 Jun;162(6):1125-32 - PubMed
  48. J Am Acad Child Adolesc Psychiatry. 2004 Jan;43(1):46-62 - PubMed
  49. Int Clin Psychopharmacol. 2007 Jul;22(4):230-7 - PubMed
  50. Behav Res Ther. 2010 Jul;48(7):675-9 - PubMed
  51. Arch Gen Psychiatry. 2004 Nov;61(11):1136-44 - PubMed
  52. Behav Ther. 2010 Mar;41(1):121-32 - PubMed
  53. J Neurosci. 2002 Mar 15;22(6):2343-51 - PubMed
  54. J Am Acad Child Adolesc Psychiatry. 2004 Dec;43(12):1488-96 - PubMed
  55. J Am Acad Child Adolesc Psychiatry. 1995 Nov;34(11):1424-31 - PubMed
  56. Biol Psychiatry. 2012 Jun 1;71(11):947-55 - PubMed
  57. Biol Psychiatry. 2010 Dec 1;68(11):1073-6 - PubMed
  58. Neuropsychopharmacology. 2007 May;32(5):1042-51 - PubMed
  59. Postgrad Med. 2012 Jan;124(1):152-65 - PubMed
  60. Biol Psychiatry. 2010 Feb 15;67(4):365-70 - PubMed
  61. Arch Gen Psychiatry. 2006 Aug;63(8):925-34 - PubMed

Publication Types

Grant support